Home / IBT-B.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does IBT-B.ST make money? Does IBT-B.ST have pricing power? What's the Earnings Whisper? Will IBT-B.ST profit more as the business scales? What is IBT-B.ST's management track record? Is IBT-B.ST's current price justified?

Infant Bacterial Therapeutics AB (publ)

SEK 65.70 +$15.90 (+31.93%)

STO · 30 Oct 2026 11:45 UTC

Previous Close

SEK 68.30

Day Range

SEK 65.10SEK 68.20

Year Range

SEK 43.25SEK 84.90

Market Cap

885.07M

AVG Volume

7.68K

Trailing/Forward PE

-10.79/2.67

PEG ratio

1.43

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · A

IBT-B.ST Revenue (SEK) by year
Period	Revenue (SEK)
2025	0
2024	4K
2023	77K
2022	9K
2021	0
2020	0
2019	0
2018	0
2017	238K
2016	162K

Net Income (SEK) · A

IBT-B.ST Net Income (SEK) by year
Period	Net Income (SEK)
2025	-65.17M
2024	-136.91M
2023	-123.07M
2022	-64.98M
2021	-44.99M
2020	-72.01M
2019	-46.32M
2018	-40.61M
2017	-36.03M
2016	-37.96M

Operating Income (SEK) · A

IBT-B.ST Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	-68.99M
2024	-145.34M
2023	-134.62M
2022	-65.81M
2021	-44.58M
2020	-71.92M
2019	-47.28M
2018	-39.42M
2017	-36.02M
2016	-38.09M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (SEK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Infant Bacterial Therapeutics AB (publ)

Earnings: IBT-B.ST

Video analysis: IBT-B.ST

News: IBT-B.ST

Similar companies